Cancer can take a tremendous toll-physically, emotionally and financially. Fortunately, there is a network of local services that patients can tap into to find support. "Every patient is different; everybody's journey is different. Someone might need a particular resource at one point, whereas another person might need the same resource at a different point," says Katie Burke, a patient navigator at Willamette Valley Cancer Institute.
A phase II study combining bendamustine and obinutuzumab showed promising results in patients with previously untreated chronic lymphocytic leukemia (CLL).
Through the development of immunotherapy, scientists are learning how to boost the body's own immune system to identify and attack cancer cells. Currently, immunotherapy is showing successful results in about 15-20 percent of cancer patients, and researchers believe more life-saving breakthroughs are on the horizon.
Genevieve White wants to know more about her family tree. And for good reason: many of her relatives on her mother's side of the family have developed some type of cancer. "I'm the first one in three generations of my family to survive colon cancer," Genevieve says. "I want to know what's going on, mostly for the sake of the next generations, like my nieces and my nephews." Genetics and cancer risk Most cancer cases [...]
Fighting throat cancer for the last 10 months has given Joseph Grace and his wife, Lodene, plenty to worry about. But one thing the couple does not have to worry about is how Joseph will get to his treatment appointments at Willamette Valley Cancer Institute.
Whether you're visiting an oncologist for the first time or seeking a second opinion, asking the right questions can help you understand important information about your diagnosis.
The National Cancer Institute estimates that more than 87,000 new cases of melanoma were diagnosed in 2017. While not as common as other forms of skin cancer, melanoma is more aggressive, and if it's not diagnosed and treated early, it can spread rapidly to other organs. Within the last 10 years, however, researchers have developed new treatments that are giving patients hope.
When Shari Pimental underwent routine surgery two years ago to remove her gallbladder, she woke up in the recovery room and learned she had stage III ovarian cancer.
Dr. Kathleen Yang, Shari's gynecologic oncologist at Willamette Valley Cancer Institute, thought Shari could possibly benefit from a clinical trial at WVCI for an investigational drug, classified as a PARP inhibitor that's designed to block specific enzymes that cancer cells need to survive.
Santa doesn't always travel by sleigh. Sometimes, holiday goodwill takes alternate forms of transportation, including the white passenger van that recently pulled into the parking lot at Willamette Valley Cancer Institute and Research Center.
Every three minutes, an American is diagnosed with a form of blood cancer. Paul Leighton of Springfield realized he was part of that statistic in 2013, when he was diagnosed with acute myeloid leukemia, brought on by a disorder that prevents stem cells from maturing and accumulating in his bone marrow.